Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2018 April;70(2) > Minerva Urologica e Nefrologica 2018 April;70(2):109-25

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Urologica e Nefrologica 2018 April;70(2):109-25

DOI: 10.23736/S0393-2249.18.03055-2

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

The role of surgery in the management of metastatic kidney cancer: an evidence-based collaborative review

M. Carmen MIR 1, Surena F. MATIN 2, Axel BEX 3, Philippe E. SPIESS 4, R. Houston THOMPSON 5, Baruch GROB 6, Hein van POPPEL 7

1 Instituto Valenciano de Oncologia Foundation, Valencia, Spain; 2 Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 3 Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; 4 Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA; 5 Department of Urology, Mayo Clinic, Rochester, MN, USA; 6 Division of Urology, Virginia Commonwealth University, Richmond, VA, USA; 7 Department of Urology, University Hospitals Leuven, Leuven, Belgium


PDF


The current manuscript aims to provide an up to date evidence based analysis on the status of surgery in the metastatic renal cell carcinoma setting. It includes the role of surgery in the primary tumor as well as recent perspective on the surgical management of metastatic disease.


KEY WORDS: Cytoreduction surgical procedures - Nephrectomy - Neoplasm metastasis - Metastasectomy - Kidney neoplasms

top of page